Skip to main content
OpenTrials

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1

NCT00115908

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
View all 87 locations
View Trial Details
Completed

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

NCT00743795

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Anaheim, California, United States
  • Los Angeles, California, United States
  • Newport Beach, California, United States
  • San Clemente, California, United States
View all 72 locations
View Trial Details
Completed

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease

NCT00529568

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Arcadia, California, United States
View all 227 locations
View Trial Details
Completed

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

NCT00516321

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site La Jolla, California, United States
View all 191 locations
View Trial Details
Completed

A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

NCT00800735

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Sacramento, California, United States
  • San Francisco, California, United States
  • Lutherville, Maryland, United States
  • Manhasset, New York, United States
View all 23 locations
View Trial Details

Related conditions